Cargando…
Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
INTRODUCTION: A higher 30-day mortality has been observed in patients with first-presentation ST elevation myocardial infarction (STEMI) who have no standard modifiable cardiovascular risk factors (SMuRFs), i. e., diabetes, hypertension, hyperlipidemia, and current smoker. In this study, we evaluate...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383416/ https://www.ncbi.nlm.nih.gov/pubmed/35990971 http://dx.doi.org/10.3389/fcvm.2022.945815 |
_version_ | 1784769396516847616 |
---|---|
author | Mazhar, Jawad Ekström, Kathrine Kozor, Rebecca Grieve, Stuart M. Nepper-Christensen, Lars Ahtarovski, Kiril A. Kelbæk, Henning Høfsten, Dan E. Køber, Lars Vejlstrup, Niels Vernon, Stephen T. Engstrøm, Thomas Lønborg, Jacob Figtree, Gemma A. |
author_facet | Mazhar, Jawad Ekström, Kathrine Kozor, Rebecca Grieve, Stuart M. Nepper-Christensen, Lars Ahtarovski, Kiril A. Kelbæk, Henning Høfsten, Dan E. Køber, Lars Vejlstrup, Niels Vernon, Stephen T. Engstrøm, Thomas Lønborg, Jacob Figtree, Gemma A. |
author_sort | Mazhar, Jawad |
collection | PubMed |
description | INTRODUCTION: A higher 30-day mortality has been observed in patients with first-presentation ST elevation myocardial infarction (STEMI) who have no standard modifiable cardiovascular risk factors (SMuRFs), i. e., diabetes, hypertension, hyperlipidemia, and current smoker. In this study, we evaluate the clinical outcomes and CMR imaging characteristics of patients with and without SMuRFs who presented with first-presentation STEMI. METHODS: Patients from the Third DANish Study of Acute Treatment of Patients With ST-Segment Elevation Myocardial Infarction (DANAMI-3) with first-presentation STEMI were classified into those with no SMuRFs vs. those with at least one SMuRF. RESULTS: We identified 2,046 patients; 283 (14%) SMuRFless and 1,763 (86%) had >0 SMuRF. SMuRFless patients were older (66 vs. 61 years, p < 0.001) with more males (84 vs. 74%, p < 0.001), more likely to have left anterior descending artery (LAD) as the culprit artery (50 vs. 42%, p = 0.009), and poor pre-PCI (percutaneous coronary intervention) TIMI (thrombolysis in myocardial infarction) flow ≤1 (78 vs. 64%; p < 0.001). There was no difference in all-cause mortality, non-fatal reinfarction, or hospitalization for heart failure at 30 days or at long-term follow-up. CMR imaging was performed on 726 patients. SMuRFless patients had larger acute infarct size (17 vs. 13%, p = 0.04) and a smaller myocardial salvage index (42 vs. 50%, p = 0.02). These differences were attenuated when the higher LAD predominance and/or TIMI 0-1 flow were included in the model. CONCLUSION: Despite no difference in 30-day mortality, SMuRFless patients had a larger infarct size and a smaller myocardial salvage index following first-presentation STEMI. This association was mediated by a larger proportion of LAD culprits and poor TIMI flow pre-PCI. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, unique identifier: NCT01435408 (DANAMI 3-iPOST and DANAMI 3-DEFER) and NCT01960933 (DANAMI 3-PRIMULTI). |
format | Online Article Text |
id | pubmed-9383416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93834162022-08-18 Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy Mazhar, Jawad Ekström, Kathrine Kozor, Rebecca Grieve, Stuart M. Nepper-Christensen, Lars Ahtarovski, Kiril A. Kelbæk, Henning Høfsten, Dan E. Køber, Lars Vejlstrup, Niels Vernon, Stephen T. Engstrøm, Thomas Lønborg, Jacob Figtree, Gemma A. Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: A higher 30-day mortality has been observed in patients with first-presentation ST elevation myocardial infarction (STEMI) who have no standard modifiable cardiovascular risk factors (SMuRFs), i. e., diabetes, hypertension, hyperlipidemia, and current smoker. In this study, we evaluate the clinical outcomes and CMR imaging characteristics of patients with and without SMuRFs who presented with first-presentation STEMI. METHODS: Patients from the Third DANish Study of Acute Treatment of Patients With ST-Segment Elevation Myocardial Infarction (DANAMI-3) with first-presentation STEMI were classified into those with no SMuRFs vs. those with at least one SMuRF. RESULTS: We identified 2,046 patients; 283 (14%) SMuRFless and 1,763 (86%) had >0 SMuRF. SMuRFless patients were older (66 vs. 61 years, p < 0.001) with more males (84 vs. 74%, p < 0.001), more likely to have left anterior descending artery (LAD) as the culprit artery (50 vs. 42%, p = 0.009), and poor pre-PCI (percutaneous coronary intervention) TIMI (thrombolysis in myocardial infarction) flow ≤1 (78 vs. 64%; p < 0.001). There was no difference in all-cause mortality, non-fatal reinfarction, or hospitalization for heart failure at 30 days or at long-term follow-up. CMR imaging was performed on 726 patients. SMuRFless patients had larger acute infarct size (17 vs. 13%, p = 0.04) and a smaller myocardial salvage index (42 vs. 50%, p = 0.02). These differences were attenuated when the higher LAD predominance and/or TIMI 0-1 flow were included in the model. CONCLUSION: Despite no difference in 30-day mortality, SMuRFless patients had a larger infarct size and a smaller myocardial salvage index following first-presentation STEMI. This association was mediated by a larger proportion of LAD culprits and poor TIMI flow pre-PCI. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, unique identifier: NCT01435408 (DANAMI 3-iPOST and DANAMI 3-DEFER) and NCT01960933 (DANAMI 3-PRIMULTI). Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9383416/ /pubmed/35990971 http://dx.doi.org/10.3389/fcvm.2022.945815 Text en Copyright © 2022 Mazhar, Ekström, Kozor, Grieve, Nepper-Christensen, Ahtarovski, Kelbæk, Høfsten, Køber, Vejlstrup, Vernon, Engstrøm, Lønborg and Figtree. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Mazhar, Jawad Ekström, Kathrine Kozor, Rebecca Grieve, Stuart M. Nepper-Christensen, Lars Ahtarovski, Kiril A. Kelbæk, Henning Høfsten, Dan E. Køber, Lars Vejlstrup, Niels Vernon, Stephen T. Engstrøm, Thomas Lønborg, Jacob Figtree, Gemma A. Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy |
title | Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy |
title_full | Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy |
title_fullStr | Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy |
title_full_unstemmed | Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy |
title_short | Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy |
title_sort | cardiovascular magnetic resonance characteristics and clinical outcomes of patients with st-elevation myocardial infarction and no standard modifiable risk factors–a danami-3 substudy |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383416/ https://www.ncbi.nlm.nih.gov/pubmed/35990971 http://dx.doi.org/10.3389/fcvm.2022.945815 |
work_keys_str_mv | AT mazharjawad cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT ekstromkathrine cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT kozorrebecca cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT grievestuartm cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT nepperchristensenlars cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT ahtarovskikirila cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT kelbækhenning cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT høfstendane cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT køberlars cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT vejlstrupniels cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT vernonstephent cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT engstrømthomas cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT lønborgjacob cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy AT figtreegemmaa cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy |